Abstract
Recently developed techniques for the investigation of iron kinetics were used to study the disturbance of iron metabolism in 19 untreated patients with Hodgkin's diseases (HD). The erythroid abnormality in newly diagnosed HD appears to be confined to those patients with systemic symptoms of weight loss, night sweats and fever, and consists of depression of marrow erythroid activity. These patients had a significnatly lower haemoglobin and serum iron concentration and a higher serum ferritin concentration, both when compared to normal subjects and to those patients with HD who lacked systemic symptoms. Ineffective erythropoiesis and red-cell destruction were not significantly increased. The present findings, confirm that HD patients with systemic symptoms have a depression of erythropoiesis, and that in these patients the marrow fails to respond to the stimulus of mild anaemia.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOWDLER A. J., PRANKERD T. A. Anaemia in the reticuloses. Br Med J. 1962 Apr 28;1(5286):1169–1175. doi: 10.1136/bmj.1.5286.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beamish M. R., Jones P. A., Trevett D., Evans I. H., Jacobs A. Iron metabolism in Hodgkin's disease. Br J Cancer. 1972 Dec;26(6):444–452. doi: 10.1038/bjc.1972.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CLINE M. J., BERLIN N. I. Anemia in Hodgkin's disease. Cancer. 1963 Apr;16:526–532. doi: 10.1002/1097-0142(196304)16:4<526::aid-cncr2820160415>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
- Cartwright G. E., Lee G. R. The anaemia of chronic disorders. Br J Haematol. 1971 Aug;21(2):147–152. doi: 10.1111/j.1365-2141.1971.tb03424.x. [DOI] [PubMed] [Google Scholar]
- Cavill I., Ricketts C., Napier J. A., Jacobs A., Trevett D., Bishop R. D. The measurement of 59Fe clearance from the plasma. Scand J Haematol. 1976 Sep;17(3):160–166. doi: 10.1111/j.1600-0609.1976.tb01171.x. [DOI] [PubMed] [Google Scholar]
- Cavill I. The preparation of 59 Fe-labelled transferrin for ferrokinetic studies. J Clin Pathol. 1971 Jul;24(5):472–474. doi: 10.1136/jcp.24.5.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Field E. O., Caughi M. N., Blackett N. M., Smithers D. W. Marrow-suppressing factors in the blood in pure red-cell aplasia, thymoma and Hodgkin's disease. Br J Haematol. 1968 Jul;15(1):101–110. doi: 10.1111/j.1365-2141.1968.tb01516.x. [DOI] [PubMed] [Google Scholar]
- Jacobs A., Slater A., Whittaker J. A., Canellos G., Wiernik P. H. Serum ferritin concentration in untreated Hodgkin's disease. Br J Cancer. 1976 Aug;34(2):162–166. doi: 10.1038/bjc.1976.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones B. M., Worwood M. An automated immunoradiometric assay for ferritin. J Clin Pathol. 1975 Jul;28(7):540–542. doi: 10.1136/jcp.28.7.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones P. A., Miller F. M., Worwood M., Jacobs A. Ferritinaemia in leukaemia and Hodgkin's disease. Br J Cancer. 1973 Mar;27(3):212–217. doi: 10.1038/bjc.1973.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
- Najean Y., Dresch C., Ardaillou N. Trouble de l'utilisation du fer hémoobinique au cours des maladies de Hodgkin évolutives. Nouv Rev Fr Hematol. 1967 Sep-Oct;7(5):739–754. [PubMed] [Google Scholar]
- Rappaport H., Berard C. W., Butler J. J., Dorfman R. F., Lukes R. J., Thomas L. B. Report of the Committee on Histopathological Criteria Contributing to Staging of Hodgkin's Disease. Cancer Res. 1971 Nov;31(11):1864–1865. [PubMed] [Google Scholar]
- Ricketts C., Jacobs A., Cavill I. Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell lifespan using 59Fe. Br J Haematol. 1975 Sep;31(1):65–75. doi: 10.1111/j.1365-2141.1975.tb00833.x. [DOI] [PubMed] [Google Scholar]
- ULTMANN J. E. The role of the spleen in the hemolytic anemia of cancer patients. Cancer Res. 1958 Sep;18(8 Pt 1):959–967. [PubMed] [Google Scholar]
- Ultmann J. E., Cunningham J. K., Gellhorn A. The clinical picture of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1047–1062. [PubMed] [Google Scholar]
- Ward H. P., Kurnick J. E., Pisarczyk M. J. Serum level of erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease. J Clin Invest. 1971 Feb;50(2):332–335. doi: 10.1172/JCI106500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whittaker J. A., Slater A., Al-Ismail S. A., Gough J., Evans K. T., Evans I. H., Crosby D. L. An assessment of laparotomy in the management of patients with Hodgkin's disease. Q J Med. 1978 Jul;47(187):291–301. [PubMed] [Google Scholar]
- YOUNG D. S., HICKS J. M. METHOD FOR THE AUTOMATIC DETERMINATION OF SERUM IRON. J Clin Pathol. 1965 Jan;18:98–102. doi: 10.1136/jcp.18.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zarrabi M. H., Lysik R., DiStefano J., Zucker S. The anaemia of chronic disorders: studies of iron reutilization in the anaemia of experimental malignancy and chronic inflammation. Br J Haematol. 1977 Apr;35(4):647–658. doi: 10.1111/j.1365-2141.1977.tb00628.x. [DOI] [PubMed] [Google Scholar]
- Zucker S., Friedman S., Lysik R. M. Bone marrow erythropoiesis in the anemia of infection, inflammation, and malignancy. J Clin Invest. 1974 Apr;53(4):1132–1138. doi: 10.1172/JCI107651. [DOI] [PMC free article] [PubMed] [Google Scholar]
